Literature DB >> 16332475

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Swee H Teh1, John Christein, John Donohue, Florencia Que, Michael Kendrick, Michael Farnell, Stephen Cha, Patrick Kamath, Raymond Kim, David M Nagorney.   

Abstract

Hepatic resection for hepatocellular carcinoma (HCC) in patients with cirrhosis is generally recommended for patients with Child-Turcotte-Pugh (CTP) Class A liver disease and early tumor stage. The Model for End-Stage Liver Disease (MELD) has been shown to accurately predict survival in patients with cirrhosis, but whether MELD is useful for selection of patients with cirrhosis for hepatic resection is unknown. We examined whether MELD was predictive of perioperative mortality and correlated MELD with other potential clinicopathologic factors to overall survival in patients with cirrhosis undergoing hepatic resection for HCC. A retrospective chart review was undertaken of patients with HCC and cirrhosis undergoing hepatic resection between 1993 and 2003. Eighty-two patients (62 men, 20 women; mean age, 62 years) were identified. Forty-five patients had MELD score > or =9 (range, 9-15) and CTP score ranged from 5 to 9 points. Fifty-nine patients underwent minor (<3 segments) hepatic resections (MELD < or =8, n = 29; MELD > or =9, n = 30) and 23 underwent major (> or =3 segments) hepatic resections (MELD < or =8, n = 8; MELD > or =9, n = 15). Perioperative mortality rate was 16%. MELD score < or =8 was associated with no perioperative mortality versus 29% for patients with an MELD score > or =9 (P < 0.01). Multivariate analysis demonstrated that MELD score > or =9 (P < 0.01), clinical tumor symptoms (P < 0.01), and ASA score (P = 0.046) are independent predictors of perioperative mortality. Multivariate analysis showed MELD > or =9 (P < 0.01), tumor size >5 cm (P < 0.01), high tumor grade (P = 0.03), and absence of tumor capsule (P < 0.01) as independent predictors of decreased long-term survival. MELD score was a strong predictor of both perioperative mortality and long-term survival in patients with cirrhosis undergoing hepatic resection for HCC. In patients with cirrhosis, hepatic resection (minor or major) for HCC is recommended if the MELD score is < or =8. In patients with MELD score > or =9, other treatment modalities should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 16332475     DOI: 10.1016/j.gassur.2005.09.008

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.267


  36 in total

Review 1.  Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Authors:  Masatoshi Kudo; Hobyung Chung; Yukio Osaki
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

2.  Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators.

Authors: 
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

Authors:  R T Poon; S T Fan; C M Lo; I O Ng; C L Liu; C M Lam; J Wong
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

4.  Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis.

Authors:  D Franco; L Capussotti; C Smadja; H Bouzari; J Meakins; F Kemeny; D Grange; M Dellepiane
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

5.  Resection of hepatocellular carcinoma: a European experience on 328 cases.

Authors:  J Belghiti; J M Regimbeau; F Durand; A R Kianmanesh; F Dondero; B Terris; A Sauvanet; O Farges; F Degos
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

8.  Compensated cirrhosis: natural history and prognostic factors.

Authors:  P Ginés; E Quintero; V Arroyo; J Terés; M Bruguera; A Rimola; J Caballería; J Rodés; C Rozman
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

9.  Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.

Authors:  N Nagasue; H Kohno; M Tachibana; A Yamanoi; H Ohmori; O N El-Assal
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

Review 10.  Critical evaluation of the different staging systems for hepatocellular carcinoma.

Authors:  S Wildi; B C Pestalozzi; L McCormack; P-A Clavien
Journal:  Br J Surg       Date:  2004-04       Impact factor: 6.939

View more
  76 in total

Review 1.  Surgical management of hepatocellular carcinoma.

Authors:  Tony Cy Pang; Vincent Wt Lam
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

3.  Predictive indices of morbidity and mortality after liver resection.

Authors:  G Ercolani; Alessandro Cucchetti; Matteo Cescon; Matteo Ravaioli; Gian Luca Grazi; Antonio D Pinna
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

4.  Predictive indices of morbidity and mortality after liver resection.

Authors:  David M Nagorney; Patrick S Kamath
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

5.  Debate: Resection for early hepatocellular carcinoma.

Authors:  Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2008-12-23       Impact factor: 3.452

6.  The impact of cirrhosis and MELD score on postoperative morbidity and mortality among patients selected for liver resection.

Authors:  Victor M Zaydfudim; Florence E Turrentine; Mark E Smolkin; Todd B Bauer; Reid B Adams; Timothy L McMurry
Journal:  Am J Surg       Date:  2020-01-20       Impact factor: 2.565

7.  Major abdominal cancer resections in cirrhotic patients: how frequent is postoperative hepatocellular decompensation?

Authors:  Shailesh Vinayak Shrikhande; Vinay Gaikwad; Dipak Purohit; Mahesh Goel
Journal:  Indian J Gastroenterol       Date:  2013-11-12

8.  Laparoscopic resection for hepatocellular carcinoma: comparison between Middle Eastern and Western experience.

Authors:  Tullio Piardi; Daniele Sommacale; Thomas Baumert; Didier Mutter; Jacques Marescaux; Patrick Pessaux
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

Review 9.  Portal vein embolization in extended liver resection.

Authors:  Nisha Narula; Thomas A Aloia
Journal:  Langenbecks Arch Surg       Date:  2017-05-31       Impact factor: 3.445

10.  Selection criteria for liver resection in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Spiros-G Delis; Christos Dervenis
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.